BAMIFIX

This brand name is authorized in Brazil

Active ingredients

The drug BAMIFIX contains one active pharmaceutical ingredient (API):

1 Bamifylline UNII 66466QLM3S - BAMIFYLLINE HYDROCHLORIDE

Bamifylline is a methylxanthinic derivative with two side chains in position 7 and 8, distinguishing it clearly from theophylline. Bamifylline carries out a bronchospasmolytic action on the smooth musculature and also blocks the action of the bronchoconstriction mediators. Unlike theophylline, bamifylline usually has no exciting effects on the central nervous system. Read about Bamifylline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BAMIFIX Tablet		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03DA08	Bamifylline	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DA Xanthines
Discover more medicines within R03DA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 508500701110418, 508500702117416